← All Lamy filings

Lamy 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

OTC.Pink
LMMY
Lamy
8-K: LAMY Acquires Exousia Ai, Pivots to Exosome Biotech
LAMY completed the acquisition of Exousia Ai, Inc., shifting its business focus to clinical-stage biotechnology developing plant-based exosome therapies for oncology, dermatology, and anti-aging.
OTC.Pink
LMMY
Lamy
8-K: LAMY Announces Change in Control with New CEO and Board
LAMY has undergone a change in control with Zhang Shengwu acquiring a majority stake and assuming leadership roles, effective December 6, 2024.
OTC.Pink
LMMY
Lamy
8-K: LAMY Appoints New Auditor, Dismisses Bush and Associates CPA
LAMY has dismissed Bush and Associates CPA as their independent auditor and appointed Boladale Lawal & Co, effective immediately.